Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer site revision/version was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:08:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and v3.4.3 removed, reflecting an update to the study protocol version.
    Difference
    0.1%
    Check dated 2026-03-18T21:55:47.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a maintenance/versioning update that does not modify the study details or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-03-11T19:57:51.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-lapse notice (v3.4.1) was removed. There are no changes to the core study details, eligibility criteria, or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T02:12:50.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding is added, informing users that the site may not be up to date and inquiries may be delayed, along with a status note about the NIH Clinical Center's operating status; the page revision changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-02-04T01:52:07.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.